Prostate Cancer
Showing NaN - NaN of 95
Prostate Cancer Trial in United States (drug, device, procedure)
Recruiting
- Prostate Cancer
- Administration of IS-002
- +2 more
-
San Francisco, California
- +3 more
Jul 7, 2023
Chemotherapy-Induced Nausea in Genitourinary Cancer and Changes
Not yet recruiting
- Bladder Cancer
- +2 more
- Blood and Tissue
-
Jacksonville, Florida
- +2 more
Apr 6, 2023
Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)
Recruiting
- Prostate Cancer
- Docetaxel 75 mg/m2
- +2 more
-
Gilbert, Arizona
- +52 more
Feb 2, 2023
Tumor Recurrence Following Radiotherapy
Recruiting
- Prostate Cancer
-
Rochester, MinnesotaMayo Clinic
Jan 20, 2023
Prostate Cancer Trial in Rochester (Focal laser ablation of the prostate)
Recruiting
- Prostate Cancer
- Focal laser ablation of the prostate
-
Rochester, MinnesotaMayo Clinic in Minnesota
Jan 9, 2023
Prostate, Lung, Melanoma and Breast Cancer Patients Following
Recruiting
- Prostate Cancer
- +3 more
- SBRT
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
SBRT for Oligometastatic Castration-Refractory Prostate Cancer
Completed
- Prostate Cancer
- SBRT
-
Rochester, MinnesotaMayo Clinic
Aug 23, 2022
Proton-Based Stereotactic Ablative Body Radiotherapy for
Active, not recruiting
- Prostate Cancer
- Proton beam
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 26, 2022
Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone
Prostate Cancer Trial in United States (Irreversible Electroporation)
Recruiting
- Prostate Cancer
- Irreversible Electroporation
-
Aurora, Colorado
- +6 more
Jul 6, 2022
Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)
Recruiting
- Prostate Cancer
- +3 more
- Curcumin plus Piperine
-
Rochester, New YorkUniversity of Rochester
Jun 17, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Prostate Cancer Trial in Worldwide (Multiparametric MRI +/- prostate biopsy, Biparametric MRI +/- prostate biopsy)
Recruiting
- Prostate Cancer
- Multiparametric MRI +/- prostate biopsy
- Biparametric MRI +/- prostate biopsy
-
Rochester, Minnesota
- +30 more
May 11, 2022
Nerve Injury, Prostate Cancer Trial in Rochester (4-Aminopyridine, Placebo)
Recruiting
- Nerve Injury
- Prostate Cancer
- 4-Aminopyridine
- Placebo
-
Rochester, New York
- +1 more
May 13, 2022
Prostate Cancer Trial in Rochester ([Ga-68] PSMA-11 PET/CT, [Ga-68] PSMA-11 PET/MR)
No longer available
- Prostate Cancer
- [Ga-68] PSMA-11 PET/CT
- [Ga-68] PSMA-11 PET/MR
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2022
Prostate Cancer Trial in Rochester (Autologous Platelet-Rich Plasma, Angel Concentrated Platelet Rich Plasma System)
Active, not recruiting
- Prostate Cancer
- Autologous Platelet-Rich Plasma
- Angel Concentrated Platelet Rich Plasma System
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 3, 2021
Prostate Cancer, HDR Trial in Rochester (High-Dose-Rate Brachytherapy)
Recruiting
- Prostate Cancer
- HDR
- High-Dose-Rate Brachytherapy
-
Rochester, New YorkUniversity of Rochester
Oct 29, 2021
Prostate Cancer Trial in Canada, United States (Brachytherapy (100/110), Brachytherapy (125/145), External Beam Radiation
Unknown status
- Prostate Cancer
- Brachytherapy (100/110)
- +2 more
-
Phoenix, Arizona
- +169 more
Nov 2, 2021
Prostate Cancer Trial in Rochester (Enzalutamide and Dutasteride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide and Dutasteride
-
Rochester, New YorkUniversity of Rochester
Nov 2, 2021